猴痘治療市場:各治療類型(預防，治療藥)，各給藥途徑，各流通管道，各地區- 規模，佔有率，展望，機會分析，2022年～2030年

Monkeypox Treatment Market, by Treatment Type (Prophylactic, Therapeutics ), by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年09月02日 | 出版商:

Coherent Market Insights | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場力學

美國衛生與公眾服務部已於 2022 年 8 月 4 日宣布猴痘爆發為突發公共衛生事件。因此，對猴痘疫苗和更好治療方法的需求正在加速。猴痘病患病率的增加以及對猴痘疫苗和新療法的需求增加預計將推動全球猴痘治療市場的增長。

本調查的主要特徵

本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球猴痘治療市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球猴痘治療市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球猴痘治療市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球猴痘治療市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

shiga·tekunorojizu
- 公司概要
- 產品系列
- 主要的焦點
- 財務效能
- 市場策略
kimerikusu公司
- 公司概要
- 產品系列
- 主要的焦點
- 財務效能
- 市場策略
拜仁·北歐
- 公司概要
- 產品系列
- 主要的焦點
- 財務實際成果
- 市場策略
SanofiSA
- 公司概要
- 產品系列
- 主要的焦點
- 財務效能
- 市場策略
emukyuafama
- 公司概要
- 產品系列
- 主要的焦點
- 財務效能
- 市場策略
濟南金們醫藥化工有限公司
- 公司概要
- 產品系列
- 主要的焦點
- 業績轉變
- 市場策略

第10章章節

調查手法
關於出版社

簡介目錄

Product Code: CMI5199

A rare condition known as monkeypox is brought on by infection with the monkeypox virus. The smallpox virus and the monkeypox virus both belong to the same virus family. Monkey pox, however, is not as contagious as smallpox. Additionally, the illness has lesser symptoms and is typically not fatal. The major symptom of Monkeypox is rash that may be located on or near the genitals.

Two outbreaks of a condition resembling the pox that were occurring in groups of monkeys being used for research led to the discovery of monkeypox in 1958. Although, skin-to-skin contact with an infected person can sometimes spread the disease, rodent contact with infected humans accounts for the majority of its transmission. The monkeypox virus has two distinct types, one of which originated in Central Africa and the other in West Africa.

The majority of those who contracted monkeypox in the past either resided and visited specific regions of central or western Africa, or exposed to diseased animals imported from such regions. The disease has been identified in residents of several nations, including the U.S., during the 2022 outbreak.

Market Dynamics

The U.S. Department of Health and Human Services, on August 4 2022 declared monkeypox outbreak as a public health emergency. Due to which there is acceleration in the demand for vaccines and better treatment for monkeypox. Increase in the prevalence of monkeypox disease and increasing demand for vaccines and new treatment for monkeypox is expected to drive growth of the global monkeypox treatment market. For instance, in June 2022, according to the WHO, since 1 January to 22 June 2022, 3413 laboratory confirmed cases and one death have been reported to the WHO from 50 countries/territories in the five WHO Regions. Moreover, 1310 new cases have been reported in eight new countries from regions like African Region, Region of the Americas, Eastern Mediterranean Region and Western Pacific Region.**One death was reported in Nigeria in the second quarter of 2022.

Key features of the study:

This report provides an in-depth analysis of the global monkeypox treatment market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global monkeypox treatment market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include SIGA Technologies, Inc., Chimerix, Inc., Bavarian Nordic, Sanofi SA, and Emcure Pharma, Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global monkeypox treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monkeypox treatment market

Detailed Segmentation:

Global Monkeypox Treatment Market, By Treatment Type:
- Prophylactic
- Vaccines
- Therapeutics
- Tecovirimat
- Brincidofovir
- Cidofovir
Global Monkeypox Treatment Market, By Route Of Administration:
- Oral
- Injectable
Global Monkeypox Treatment Market, By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Global Monkeypox Treatment Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- SIGA Technologies
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Chimerix, Inc.
- Bavarian Nordic
- Sanofi SA.
- Emcure Pharma
- Jinan Jinda Pharmaceutical Chemistry Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, by Treatment Type
- Market Snapshot, by Route Of Administration
- Market Snapshot, by Distribution Channel
- Market Snapshot, by Region
- Market Opportunity Map

3. Global Monkeypox Treatment Market Insights

Drivers
Restraints
Opportunity
Impact Analysis
Market Trends
Key Developments
Product Launch/Approval
Regulatory Scenario
Acquisitions, Collaborations & Partnerships Scenario
Epidemiology
PEST Analysis
Pipeline Analysis

4. Global Monkeypox Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact On Supply And Demand

5. Global Monkeypox Treatment Market, By Treatment Type, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Prophylactic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
- Vaccine
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
- Tecovirimat
- Brincidofovir
- Cidofovir

6. Global Monkeypox Treatment Market, By Route of Administration, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)

7. Global Monkeypox Treatment Market, By Distribution Channel, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)

8. Global Monkeypox Treatment Market, By Region, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Region at Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2017-2030, (US$ Million)
South Africa
Central Africa
North Africa

9. Company Profiles

SIGA Technologies Inc.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chimerix, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bavarian Nordic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Emcure Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies